Participants agree that individual biology and external factors cause varied responses to the same medication, consistent with pharmacology. Study results can appear uniform because dropouts are assigned to failure groups and non-responders may be removed. Most attribute apparent differences between sources to dosing errors or degradation rather than inherent chemical distinctions in the API itself. No detailed orbital or conformational explanation for API variability was provided.
What this discussion establishesSome emphasize individual human variability as the main cause while others question whether the same API can truly differ chemically between sources
Still openWhether HPLC can distinguish very similar molecules and what specific conformational or orbital differences could exist in the API
Nothing here is advice.
Everyone repeats that tirz is just tirz, but the shared view is that people react differently and even different compounders' versions act differently. That clashes with pharmacology basics for generics and with chemistry. Apart from getting shorted on milligrams from mistakes or breakdown, what scientific reason supports the belief? Explain it like I'm five but a very demanding five. I've read semi-technical forum posts suggesting the same API could still be different somehow, yet it's never been clear chemically what that would mean. Maybe HPLC fails to separate very similar molecules? If so, how does that still confirm identity? I'd like chemistry-level answers using ideas like electrons, orbitals or conformation, perhaps a theoretical example, instead of general statements.
I'm not diving into the chemistry details, but as a medical professional I can say this does not contradict basic pharmacology. People respond differently to any medication, even at the same dose from the same maker. We expect broadly similar outcomes, yet thousands of biological and environmental factors shape each person's reaction.
Yes and no. What I'm trying to say is that we've taken the idea of variable responses to an extreme. Approved medications must show predictable overall behavior, expected results under a strict protocol, and work for the great majority of people with the right diagnosis. An alternate question is why the qualifying studies don't reflect this variability. Everyone followed the same protocols and ninety percent lost a large amount of weight without dose changes. One reason the belief persists is that telehealth providers answer patient questions while having an incentive to keep people enrolled. GLP users also absorb what they're told. The generic concept rests on tirz being tirz. Still, if someone can show chemical or biochemical variability I'm open to changing my view. Right now I'm more agnostic.
Study results can be skewed because participants drop out or are removed for various reasons, and some may even lie about outcomes. I once joined a medication study and after weeks said it wasn't working. They warned me I'd be dropped if it still wasn't working at the next visit. Since I was nineteen and getting paid a small amount, I lied to stay in. At the time I didn't grasp how unethical that was. Weight is harder to lie about unless self-reported, but non-responders could have been removed. Podcasts and videos on GLP-1s might help, such as Fat Science with Dr Emily Cooper. A used pharmacology textbook could also be useful.
That's a fair point. Dropouts are handled in the stats by placing them in the failure group, which is harsh but correct. So we don't have to worry about that unless the study is seriously flawed, and FDA ones usually aren't. You found why participants should be true volunteers. For a hard-to-get drug like reta, people might still lie to stay in and stockpile. The sponsor can avoid that temptation by promising an equal period of free drug afterward, which also allows a crossover design. I have pharmacology books but probably need deeper chemistry ones. Will check out the podcast, thanks.
That took me way too long to figure out.
Some of us have brains packed only with stuff like this.
I first thought it meant Tuesday or Friday, which made no sense at all.
I like that one. It reminds me how much creativity I've lost with age.
This is the answer. Human bodies aren't machines that always give the same output for the same input. Genetics, anatomy, race, environment, diet and many other variables differ. Tirz equals tirz is probably true, but one person does not equal another. Studies show average effects across many people, yet the drug won't behave the same for everyone. Some can't tolerate the side effects while others do better than trial results. Variability between batches or sources is more likely from degradation, under-dosing or concentration issues.
After going through all the steps, waiting nearly a month, keeping sterility and mixing to the right strength, you still shouldn't inject half a milliliter the first time. It makes me wonder how many people get impatient and do exactly that.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.